ZL-6301

N/A

Report date: 2024/08/07 14:27:18

Base Information

Drug NameZL-6301
Drug Alias NameZL-6301
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Inactive tyrosine-protein kinase transmembrane receptor ROR1
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Mycos Biomedicine Co LtdZai Lab Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZai Lab Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A